Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
Director departure

ChemoCentryx, Inc. (CCXI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/31/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Parker Geoffrey M. (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Disposed/sold 107,997 shares @ $0
Disposed/sold 21,076 shares @ $0
Disposed/sold 5,000 shares @ $0
Disposed/sold 8,342 options @ $22.39, valued at $186.8k
Disposed/sold 4,504 options @ $10.06, valued at $45.3k
Disposed/sold 12,287 options @ $11.6, valued at $142.5k
Disposed/sold 13,352 options @ $12.94, valued at $172.8k
Disposed/sold 12,500 options @ $13.94, valued at $174.3k
Disposed/sold 15,723 restricted stock units @ $0
10/24/2022 4 KANAYA SUSAN M (See Remarks) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Disposed/sold 91,317 shares @ $0
Disposed/sold 132,717 shares @ $0
Disposed/sold 71,280 options @ $29.83, valued at $2.1M
Disposed/sold 3,920 options @ $29.83, valued at $116.9k
Disposed/sold 2,198 options @ $46.59, valued at $102.4k
Disposed/sold 19,202 options @ $46.59, valued at $894.6k
Disposed/sold 51,518 options @ $11.02, valued at $567.7k
Disposed/sold 8,482 options @ $11.02, valued at $93.5k
Disposed/sold 10,102 options @ $10.86, valued at $109.7k
Disposed/sold 25,000 options @ $10.86, valued at $271.5k
Disposed/sold 72,826 options @ $6.62, valued at $482.1k
10/24/2022 4 Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Disposed/sold 9,138 shares @ $0
Disposed/sold 8,342 options @ $22.39, valued at $186.8k
Disposed/sold 4,504 options @ $10.06, valued at $45.3k
Disposed/sold 12,287 options @ $11.6, valued at $142.5k
Disposed/sold 13,352 options @ $12.94, valued at $172.8k
Disposed/sold 12,500 options @ $13.94, valued at $174.3k
Disposed/sold 15,723 restricted stock units @ $0
10/24/2022 4 FECZKO JOSEPH M (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Disposed/sold 148,127 shares @ $0
Disposed/sold 8,342 options @ $22.39, valued at $186.8k
Disposed/sold 4,504 options @ $10.06, valued at $45.3k
Disposed/sold 12,287 options @ $11.6, valued at $142.5k
Disposed/sold 13,352 options @ $12.94, valued at $172.8k
Disposed/sold 12,500 options @ $13.94, valued at $174.3k
Disposed/sold 15,723 restricted stock units @ $0
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Wheadon David E. (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Disposed/sold 22,274 restricted stock units @ $0
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/20/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/20/2022 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
10/20/2022 8-K Quarterly results
10/20/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/18/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
10/07/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/14/2022 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
09/12/2022 SC 13G/A FMR LLC reports a 0% stake in CHEMOCENTRYX INC
08/31/2022 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
08/18/2022 4 KANAYA SUSAN M (EVP, CFO and Sec.) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Sold 19,898 shares @ $50.9495, valued at $1M
Exercised 19,898 options to buy @ $10.86, valued at $216.1k
08/09/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/08/2022 4 Schall Thomas J. (President and CEO) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Sold 130,000 shares @ $50.2441, valued at $6.5M
Exercised 130,000 options to buy @ $14.28, valued at $1.9M
08/08/2022 4 KANAYA SUSAN M (EVP, CFO and Sec.) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Sold 46,298 shares @ $50.1688, valued at $2.3M
Exercised 14,583 options to buy @ $6.23, valued at $90.9k
Exercised 31,715 options to buy @ $6.62, valued at $210k
08/08/2022 4 Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Sold 10,000 shares @ $50.22, valued at $502.2k
08/08/2022 4 Cappel Markus J. (Chief Bus. Officer & Treasurer) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Sold 7,564 shares @ $50.22, valued at $379.9k
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/04/2022 8-K Quarterly results
07/05/2022 8-K Quarterly results
06/30/2022 4 Herron Jennifer Lyn (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns: Granted 17,237 shares @ $0
06/30/2022 3 Herron Jennifer Lyn (Director) has filed a Form 3 on ChemoCentryx, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy